Delayed contamination detection wastes material and capacity. This is made worse in integrated/continuous processing.
Identification of rapid methods (results in 8 hours or less) and integration of those methods into quality systems.
Waste of product and downtime due to contamination is reduced.
Login to the NIIMBL member portal to access more, including:
Not yet a member? Learn more about which level of NIIMBL membership is right for you and your organization.
NIIMBL
AstraZeneca
Bristol-Myers Squibb
CSL Behring, LLC
Catalent Pharma Solutions, LLC
Cytiva
Eli Lilly and Company
Genentech, Inc.
GlaxoSmithKline, LLC
Janssen Research & Development, LLC
Merck Sharp & Dohme LLC
MilliporeSigma/EMD Serono
Pfizer, Inc.
Resilience US
Sanofi
Sartorius Stedim